Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fat Emulsions, Intravenous | 62 | 2023 | 321 | 10.110 |
Why?
|
Parenteral Nutrition | 86 | 2024 | 650 | 9.980 |
Why?
|
Fish Oils | 52 | 2023 | 469 | 6.950 |
Why?
|
Intestinal Diseases | 24 | 2024 | 531 | 4.640 |
Why?
|
Soybean Oil | 30 | 2023 | 133 | 4.320 |
Why?
|
Liver Diseases | 30 | 2024 | 1252 | 3.960 |
Why?
|
Cholestasis | 26 | 2023 | 378 | 3.370 |
Why?
|
Short Bowel Syndrome | 23 | 2024 | 345 | 2.770 |
Why?
|
Enteral Nutrition | 24 | 2023 | 763 | 1.750 |
Why?
|
Fatty Acids, Essential | 16 | 2020 | 95 | 1.670 |
Why?
|
Parenteral Nutrition, Total | 13 | 2022 | 300 | 1.660 |
Why?
|
Parenteral Nutrition Solutions | 10 | 2021 | 27 | 1.330 |
Why?
|
Aluminum | 4 | 2017 | 152 | 1.230 |
Why?
|
Liver Failure | 7 | 2024 | 240 | 0.980 |
Why?
|
Pharmacy Service, Hospital | 3 | 2019 | 133 | 0.900 |
Why?
|
Nutritional Requirements | 5 | 2019 | 285 | 0.870 |
Why?
|
Dietary Fats | 11 | 2019 | 2017 | 0.800 |
Why?
|
Fatty Acids, Omega-3 | 15 | 2019 | 1341 | 0.770 |
Why?
|
Triglycerides | 19 | 2023 | 2450 | 0.750 |
Why?
|
Intestines | 10 | 2024 | 1923 | 0.750 |
Why?
|
Growth | 3 | 2020 | 376 | 0.710 |
Why?
|
Drug Contamination | 2 | 2014 | 148 | 0.710 |
Why?
|
Parenteral Nutrition, Home | 5 | 2021 | 35 | 0.700 |
Why?
|
Catheter-Related Infections | 7 | 2023 | 252 | 0.700 |
Why?
|
Bilirubin | 11 | 2023 | 424 | 0.690 |
Why?
|
Fatty Liver | 11 | 2023 | 728 | 0.660 |
Why?
|
Deficiency Diseases | 3 | 2017 | 72 | 0.660 |
Why?
|
Infant Nutritional Physiological Phenomena | 7 | 2021 | 347 | 0.620 |
Why?
|
Infant Nutrition Disorders | 1 | 2017 | 73 | 0.600 |
Why?
|
Infant | 45 | 2022 | 35070 | 0.580 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2017 | 303 | 0.560 |
Why?
|
Micronutrients | 3 | 2017 | 375 | 0.550 |
Why?
|
Dietary Supplements | 10 | 2017 | 3294 | 0.540 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 149 | 0.540 |
Why?
|
Nutritional Status | 6 | 2022 | 1606 | 0.540 |
Why?
|
Catheterization, Central Venous | 7 | 2023 | 514 | 0.520 |
Why?
|
Gastrointestinal Diseases | 4 | 2019 | 1167 | 0.500 |
Why?
|
Malabsorption Syndromes | 3 | 2019 | 135 | 0.480 |
Why?
|
Infant, Premature | 8 | 2021 | 2041 | 0.480 |
Why?
|
Infant, Newborn | 34 | 2023 | 25575 | 0.470 |
Why?
|
Infant, Premature, Diseases | 6 | 2021 | 706 | 0.470 |
Why?
|
Infant, Very Low Birth Weight | 3 | 2021 | 406 | 0.460 |
Why?
|
Fatty Acids | 12 | 2023 | 1806 | 0.450 |
Why?
|
Swimming | 1 | 2013 | 206 | 0.430 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 778 | 0.430 |
Why?
|
Critical Illness | 6 | 2022 | 2665 | 0.400 |
Why?
|
Docosahexaenoic Acids | 8 | 2017 | 875 | 0.400 |
Why?
|
Child Development | 4 | 2019 | 2222 | 0.400 |
Why?
|
Drug Compounding | 5 | 2020 | 242 | 0.380 |
Why?
|
Energy Intake | 9 | 2023 | 2147 | 0.370 |
Why?
|
alpha-Tocopherol | 3 | 2019 | 127 | 0.360 |
Why?
|
Intestinal Absorption | 4 | 2024 | 420 | 0.360 |
Why?
|
Aspartate Aminotransferases | 4 | 2020 | 418 | 0.350 |
Why?
|
Food, Formulated | 1 | 2010 | 109 | 0.350 |
Why?
|
Arachidonic Acid | 5 | 2017 | 434 | 0.320 |
Why?
|
Child | 41 | 2023 | 77478 | 0.320 |
Why?
|
Protective Agents | 2 | 2019 | 156 | 0.310 |
Why?
|
Humans | 126 | 2024 | 742088 | 0.310 |
Why?
|
Medication Errors | 4 | 2017 | 797 | 0.300 |
Why?
|
Intestinal Volvulus | 2 | 2023 | 65 | 0.280 |
Why?
|
Child, Preschool | 20 | 2020 | 40955 | 0.280 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 344 | 0.270 |
Why?
|
Phytosterols | 4 | 2019 | 65 | 0.270 |
Why?
|
Liver | 15 | 2023 | 7470 | 0.270 |
Why?
|
Bone Diseases, Metabolic | 3 | 2014 | 417 | 0.270 |
Why?
|
Practice Guidelines as Topic | 9 | 2021 | 7276 | 0.260 |
Why?
|
Hyperlipidemias | 1 | 2010 | 786 | 0.260 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 293 | 0.240 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2012 | 340 | 0.240 |
Why?
|
Plant Oils | 5 | 2016 | 202 | 0.240 |
Why?
|
Bacteremia | 3 | 2023 | 962 | 0.240 |
Why?
|
Drug Incompatibility | 2 | 2021 | 11 | 0.240 |
Why?
|
Phospholipids | 6 | 2013 | 781 | 0.240 |
Why?
|
Infant, Low Birth Weight | 3 | 2012 | 850 | 0.230 |
Why?
|
Alkaline Phosphatase | 3 | 2017 | 865 | 0.230 |
Why?
|
Alanine Transaminase | 4 | 2018 | 592 | 0.230 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2023 | 158 | 0.230 |
Why?
|
Disease Models, Animal | 21 | 2023 | 18006 | 0.230 |
Why?
|
Swine | 8 | 2024 | 5934 | 0.210 |
Why?
|
Linoleic Acid | 3 | 2017 | 157 | 0.210 |
Why?
|
Male | 60 | 2023 | 349538 | 0.200 |
Why?
|
Liver Function Tests | 4 | 2014 | 528 | 0.200 |
Why?
|
Emulsions | 6 | 2023 | 155 | 0.190 |
Why?
|
Nursing Staff, Hospital | 1 | 2004 | 346 | 0.190 |
Why?
|
Refeeding Syndrome | 1 | 2020 | 14 | 0.190 |
Why?
|
Intestinal Neoplasms | 1 | 2023 | 319 | 0.180 |
Why?
|
Lipids | 5 | 2012 | 3302 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2023 | 62966 | 0.180 |
Why?
|
Drug Evaluation | 1 | 2021 | 637 | 0.180 |
Why?
|
PPAR gamma | 2 | 2023 | 493 | 0.180 |
Why?
|
Pharmacists | 2 | 2019 | 240 | 0.180 |
Why?
|
Antithrombins | 1 | 2022 | 304 | 0.180 |
Why?
|
Digestive System Surgical Procedures | 2 | 2023 | 576 | 0.180 |
Why?
|
Recovery of Function | 1 | 2010 | 2924 | 0.170 |
Why?
|
Animals | 43 | 2024 | 168561 | 0.170 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1864 | 0.170 |
Why?
|
Liver Transplantation | 4 | 2020 | 2117 | 0.170 |
Why?
|
Intestine, Small | 2 | 2023 | 1243 | 0.170 |
Why?
|
Hospitals, Pediatric | 5 | 2016 | 1760 | 0.170 |
Why?
|
Product Labeling | 1 | 2019 | 79 | 0.170 |
Why?
|
Heparin | 2 | 2023 | 1636 | 0.160 |
Why?
|
United States Food and Drug Administration | 3 | 2014 | 1581 | 0.160 |
Why?
|
Mice, Inbred C57BL | 17 | 2022 | 21821 | 0.160 |
Why?
|
Latex | 1 | 1997 | 52 | 0.160 |
Why?
|
Nutrition Assessment | 2 | 2020 | 723 | 0.160 |
Why?
|
Endotoxemia | 1 | 2019 | 206 | 0.160 |
Why?
|
Retrospective Studies | 23 | 2023 | 77098 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2015 | 5425 | 0.150 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 306 | 0.150 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 134 | 0.150 |
Why?
|
Female | 45 | 2024 | 379592 | 0.150 |
Why?
|
Intubation, Gastrointestinal | 1 | 2018 | 153 | 0.150 |
Why?
|
Vitamin K | 1 | 2019 | 294 | 0.150 |
Why?
|
Nutritional Support | 2 | 2022 | 168 | 0.150 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2016 | 1130 | 0.140 |
Why?
|
Infection Control | 1 | 2004 | 962 | 0.140 |
Why?
|
Energy Metabolism | 4 | 2012 | 2896 | 0.140 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1997 | 282 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2020 | 21719 | 0.140 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 13 | 0.140 |
Why?
|
Mucolipidoses | 2 | 2019 | 82 | 0.140 |
Why?
|
Feeding Methods | 1 | 2016 | 35 | 0.140 |
Why?
|
Rest | 2 | 2012 | 900 | 0.140 |
Why?
|
Medication Reconciliation | 1 | 2017 | 151 | 0.130 |
Why?
|
Pruritus | 1 | 2019 | 359 | 0.130 |
Why?
|
Dietary Proteins | 1 | 2020 | 963 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2010 | 4231 | 0.130 |
Why?
|
Patient Transfer | 1 | 2022 | 760 | 0.130 |
Why?
|
Vitamin E | 1 | 2019 | 869 | 0.130 |
Why?
|
Cross Infection | 1 | 2004 | 1413 | 0.130 |
Why?
|
Gastric Emptying | 1 | 2017 | 233 | 0.130 |
Why?
|
Disease Outbreaks | 1 | 2004 | 1768 | 0.120 |
Why?
|
Weight Gain | 5 | 2020 | 2282 | 0.120 |
Why?
|
Ileum | 1 | 2017 | 565 | 0.120 |
Why?
|
Postoperative Care | 2 | 2018 | 1484 | 0.120 |
Why?
|
Citrulline | 1 | 2014 | 105 | 0.120 |
Why?
|
Hair | 1 | 2017 | 483 | 0.120 |
Why?
|
United States | 17 | 2022 | 69693 | 0.120 |
Why?
|
Sterilization | 1 | 2014 | 134 | 0.120 |
Why?
|
PPAR alpha | 2 | 2023 | 196 | 0.110 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 226 | 0.110 |
Why?
|
Mucositis | 1 | 2014 | 101 | 0.110 |
Why?
|
Malnutrition | 2 | 2016 | 625 | 0.110 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2013 | 227 | 0.110 |
Why?
|
Inflammation | 4 | 2024 | 10578 | 0.110 |
Why?
|
Medication Systems, Hospital | 1 | 1993 | 158 | 0.110 |
Why?
|
Stomach | 1 | 2017 | 697 | 0.100 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2271 | 0.100 |
Why?
|
Body Fluid Compartments | 1 | 2011 | 52 | 0.100 |
Why?
|
Health Care Rationing | 1 | 2015 | 435 | 0.100 |
Why?
|
Gastrointestinal Tract | 2 | 2016 | 814 | 0.100 |
Why?
|
Mice | 21 | 2023 | 81045 | 0.100 |
Why?
|
Hyperbilirubinemia | 2 | 2016 | 77 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1221 | 0.100 |
Why?
|
Adolescent | 15 | 2020 | 85649 | 0.100 |
Why?
|
Mouth Mucosa | 1 | 2014 | 434 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1025 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 9941 | 0.100 |
Why?
|
Lipid Regulating Agents | 1 | 2010 | 24 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2023 | 3748 | 0.090 |
Why?
|
Maximum Allowable Concentration | 1 | 2010 | 62 | 0.090 |
Why?
|
Cysteine | 1 | 2015 | 873 | 0.090 |
Why?
|
Ethanol | 2 | 2023 | 1337 | 0.090 |
Why?
|
Interleukin-6 | 4 | 2019 | 3199 | 0.090 |
Why?
|
Age Factors | 5 | 2019 | 18355 | 0.090 |
Why?
|
Adult | 18 | 2023 | 213712 | 0.090 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2012 | 546 | 0.090 |
Why?
|
Health | 1 | 2012 | 390 | 0.090 |
Why?
|
Prospective Studies | 13 | 2021 | 53187 | 0.090 |
Why?
|
Growth Disorders | 1 | 2014 | 643 | 0.090 |
Why?
|
C-Reactive Protein | 5 | 2020 | 3766 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1788 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 7153 | 0.080 |
Why?
|
Eicosapentaenoic Acid | 4 | 2017 | 582 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 817 | 0.080 |
Why?
|
Food Contamination | 1 | 2010 | 189 | 0.080 |
Why?
|
Osmolar Concentration | 1 | 2009 | 683 | 0.080 |
Why?
|
Hypersensitivity | 1 | 1997 | 1093 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3861 | 0.080 |
Why?
|
Bile Acids and Salts | 2 | 2023 | 353 | 0.080 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 250 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.080 |
Why?
|
Biliary Tract | 1 | 2008 | 134 | 0.070 |
Why?
|
Vomiting | 2 | 2023 | 632 | 0.070 |
Why?
|
Probability | 2 | 2014 | 2502 | 0.070 |
Why?
|
Streptomyces | 2 | 1997 | 89 | 0.070 |
Why?
|
Family | 1 | 2018 | 3144 | 0.070 |
Why?
|
Risk Factors | 9 | 2020 | 72145 | 0.070 |
Why?
|
Serum Albumin | 1 | 2009 | 674 | 0.070 |
Why?
|
Glutamine | 2 | 2012 | 574 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1636 | 0.070 |
Why?
|
Bone and Bones | 2 | 2014 | 2575 | 0.070 |
Why?
|
Metabolome | 1 | 2013 | 881 | 0.070 |
Why?
|
Glucose | 4 | 2017 | 4391 | 0.070 |
Why?
|
Incidence | 6 | 2022 | 20928 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 904 | 0.070 |
Why?
|
Electrolytes | 3 | 2017 | 282 | 0.070 |
Why?
|
Vitamins | 3 | 2022 | 1608 | 0.070 |
Why?
|
Immunity | 1 | 2012 | 1011 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2885 | 0.070 |
Why?
|
Consumer Product Safety | 1 | 2006 | 122 | 0.070 |
Why?
|
Cholecystitis, Acute | 1 | 2006 | 70 | 0.070 |
Why?
|
Microvilli | 2 | 2019 | 241 | 0.070 |
Why?
|
Societies, Scientific | 2 | 2018 | 220 | 0.070 |
Why?
|
Clinical Competence | 2 | 2018 | 4681 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1331 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3300 | 0.060 |
Why?
|
Ceftriaxone | 1 | 2006 | 168 | 0.060 |
Why?
|
Osteoporosis | 1 | 2015 | 1581 | 0.060 |
Why?
|
Body Composition | 2 | 2011 | 2400 | 0.060 |
Why?
|
Anemia | 1 | 2014 | 1499 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6249 | 0.060 |
Why?
|
Amino Acids | 3 | 2017 | 1727 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2023 | 2723 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1889 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2276 | 0.060 |
Why?
|
Metabolomics | 1 | 2013 | 1467 | 0.060 |
Why?
|
Hypoglycemia | 1 | 2011 | 859 | 0.060 |
Why?
|
Cholelithiasis | 1 | 2006 | 411 | 0.060 |
Why?
|
Risk Assessment | 3 | 2019 | 23320 | 0.060 |
Why?
|
Tyramine | 1 | 2023 | 52 | 0.060 |
Why?
|
Selegiline | 1 | 2023 | 31 | 0.060 |
Why?
|
Diet | 4 | 2024 | 7923 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.060 |
Why?
|
Abdominal Pain | 2 | 2023 | 1059 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5724 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2006 | 495 | 0.060 |
Why?
|
Double-Blind Method | 6 | 2015 | 12017 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2010 | 848 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2011 | 1368 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 286 | 0.050 |
Why?
|
Radiotherapy | 1 | 2010 | 1525 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2506 | 0.050 |
Why?
|
Adipose Tissue | 2 | 2011 | 3278 | 0.050 |
Why?
|
Fibrosis | 2 | 2023 | 2026 | 0.050 |
Why?
|
Cell Membrane | 3 | 2012 | 3744 | 0.050 |
Why?
|
Bone Density | 1 | 2015 | 3469 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2951 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 391 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2935 | 0.050 |
Why?
|
Swine, Miniature | 1 | 2023 | 961 | 0.050 |
Why?
|
Equipment Design | 1 | 2009 | 3582 | 0.050 |
Why?
|
Area Under Curve | 2 | 2017 | 1653 | 0.050 |
Why?
|
Safety | 1 | 2005 | 1185 | 0.050 |
Why?
|
Reference Values | 1 | 2008 | 4982 | 0.050 |
Why?
|
Living Donors | 1 | 2005 | 618 | 0.050 |
Why?
|
Length of Stay | 3 | 2020 | 6294 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 334 | 0.050 |
Why?
|
Parents | 1 | 2013 | 3387 | 0.040 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1887 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9581 | 0.040 |
Why?
|
Young Adult | 5 | 2020 | 56350 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2211 | 0.040 |
Why?
|
Survival Rate | 2 | 2014 | 12773 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2714 | 0.040 |
Why?
|
Tyrosine | 1 | 2023 | 1460 | 0.040 |
Why?
|
Infant Formula | 1 | 2020 | 199 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 839 | 0.040 |
Why?
|
Societies, Medical | 3 | 2020 | 3740 | 0.040 |
Why?
|
Phosphorus | 1 | 2020 | 338 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 86 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 317 | 0.040 |
Why?
|
Time Factors | 7 | 2020 | 40054 | 0.040 |
Why?
|
Body Mass Index | 2 | 2016 | 12695 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1402 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 372 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15530 | 0.040 |
Why?
|
Spectrophotometry, Atomic | 1 | 2017 | 81 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 425 | 0.040 |
Why?
|
Anthropometry | 2 | 2015 | 1350 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1179 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 365 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4414 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 780 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2763 | 0.040 |
Why?
|
Filtration | 1 | 2018 | 234 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6534 | 0.040 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 34 | 0.040 |
Why?
|
alpha-Linolenic Acid | 1 | 2017 | 144 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2018 | 137 | 0.040 |
Why?
|
Rats | 3 | 2022 | 24265 | 0.040 |
Why?
|
Magnesium | 1 | 2020 | 813 | 0.040 |
Why?
|
Birth Weight | 2 | 2016 | 2068 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.040 |
Why?
|
Body Weight | 2 | 2018 | 4664 | 0.030 |
Why?
|
Language Development | 1 | 2017 | 187 | 0.030 |
Why?
|
Pilot Projects | 3 | 2018 | 8297 | 0.030 |
Why?
|
Micelles | 1 | 2017 | 203 | 0.030 |
Why?
|
Gastrointestinal Transit | 1 | 2017 | 96 | 0.030 |
Why?
|
Safflower Oil | 1 | 2015 | 29 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 808 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2023 | 15244 | 0.030 |
Why?
|
Potassium | 1 | 2020 | 1336 | 0.030 |
Why?
|
Infant Food | 1 | 1995 | 141 | 0.030 |
Why?
|
Patient Care Team | 2 | 2022 | 2527 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39004 | 0.030 |
Why?
|
Drug Labeling | 1 | 2017 | 231 | 0.030 |
Why?
|
Solutions | 2 | 2011 | 426 | 0.030 |
Why?
|
Vietnam | 1 | 2016 | 408 | 0.030 |
Why?
|
Dietetics | 1 | 2014 | 35 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10248 | 0.030 |
Why?
|
Gastroparesis | 1 | 2017 | 131 | 0.030 |
Why?
|
Cesarean Section | 1 | 2023 | 1363 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2016 | 372 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 518 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 60 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4771 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2384 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2789 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 600 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 544 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2253 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1372 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2425 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 270 | 0.030 |
Why?
|
Membrane Lipids | 1 | 2013 | 248 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2013 | 3081 | 0.030 |
Why?
|
Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
Boston | 2 | 2016 | 9305 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 839 | 0.030 |
Why?
|
Bacteria | 2 | 2000 | 2102 | 0.030 |
Why?
|
Diarrhea, Infantile | 1 | 2011 | 109 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2000 | 1389 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13921 | 0.020 |
Why?
|
Lung | 2 | 2022 | 9826 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1146 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1420 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 402 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2015 | 1583 | 0.020 |
Why?
|
Instillation, Drug | 1 | 2010 | 32 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 3695 | 0.020 |
Why?
|
Checklist | 1 | 2018 | 830 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1394 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 780 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1107 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2011 | 279 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3211 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 317 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2359 | 0.020 |
Why?
|
Adipogenesis | 1 | 2012 | 358 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2451 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10943 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6483 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 213127 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 846 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 183 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2640 | 0.020 |
Why?
|
Milk | 1 | 2012 | 449 | 0.020 |
Why?
|
Reference Standards | 1 | 1993 | 1020 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13256 | 0.020 |
Why?
|
Probiotics | 1 | 2012 | 351 | 0.020 |
Why?
|
Arginine | 1 | 2012 | 944 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 1997 | 1071 | 0.020 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2008 | 62 | 0.020 |
Why?
|
Lipogenesis | 1 | 2010 | 212 | 0.020 |
Why?
|
Data Collection | 1 | 1997 | 3339 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8541 | 0.020 |
Why?
|
Cognition | 2 | 2017 | 6722 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2030 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 490 | 0.020 |
Why?
|
Germany | 1 | 2009 | 860 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 854 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2010 | 302 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5948 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4214 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9639 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13655 | 0.020 |
Why?
|
Mental Disorders | 1 | 2006 | 6587 | 0.020 |
Why?
|
Odds Ratio | 2 | 2013 | 9846 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 12730 | 0.020 |
Why?
|
Trace Elements | 1 | 2007 | 198 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 941 | 0.020 |
Why?
|
Medical Errors | 1 | 2014 | 1296 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3913 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2566 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2485 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2011 | 1726 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 24913 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3528 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3490 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3339 | 0.020 |
Why?
|
Cohort Studies | 1 | 2008 | 40450 | 0.020 |
Why?
|
Antioxidants | 1 | 2013 | 1659 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3062 | 0.020 |
Why?
|
Treatment Failure | 1 | 2010 | 2615 | 0.020 |
Why?
|
Transcription Factors | 1 | 2004 | 12164 | 0.010 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2006 | 224 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3111 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14554 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1813 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 137 | 0.010 |
Why?
|
Premature Birth | 1 | 2016 | 1713 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8621 | 0.010 |
Why?
|
Aged | 3 | 2023 | 162944 | 0.010 |
Why?
|
Breast Feeding | 1 | 2011 | 1339 | 0.010 |
Why?
|
Mice, Obese | 1 | 2004 | 424 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23387 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3462 | 0.010 |
Why?
|
Gastrointestinal Agents | 1 | 2007 | 494 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3738 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12242 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4369 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3711 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2536 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29010 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10372 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2611 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1643 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 1993 | 2217 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6756 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4886 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29087 | 0.010 |
Why?
|
Cholesterol | 1 | 2010 | 2895 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2354 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1310 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10392 | 0.010 |
Why?
|
Hospitalization | 2 | 2016 | 10232 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1820 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15194 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1839 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8300 | 0.010 |
Why?
|
Protoplasts | 1 | 1997 | 44 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7901 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8662 | 0.010 |
Why?
|
Mycoses | 1 | 2000 | 376 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2589 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19862 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1413 | 0.010 |
Why?
|
Cell Wall | 1 | 1997 | 422 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2000 | 1871 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 5979 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1997 | 2203 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5385 | 0.000 |
Why?
|
Brain | 1 | 2012 | 26343 | 0.000 |
Why?
|
Algorithms | 1 | 2002 | 13853 | 0.000 |
Why?
|
Neoplasms | 1 | 2010 | 21596 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 35342 | 0.000 |
Why?
|